Litigation Details for Eagle Pharmaceuticals, Inc. v. Hospira, Inc. (D. Del. 2021)
✉ Email this page to a colleague
Eagle Pharmaceuticals, Inc. v. Hospira, Inc. (D. Del. 2021)
Docket | ⤷ Sign Up | Date Filed | 2021-11-15 |
Court | District Court, D. Delaware | Date Terminated | 2022-04-19 |
Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
Jury Demand | None | Referred To | |
Parties | HOSPIRA, INC. | ||
Patents | 9,000,021; 9,034,908; 9,144,568; 9,572,887; 9,579,384; 9,597,397; 9,597,398; 9,597,399 | ||
Attorneys | Alan Richard Silverstein | ||
Firms | Shaw Keller LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Eagle Pharmaceuticals, Inc. v. Hospira, Inc.
Details for Eagle Pharmaceuticals, Inc. v. Hospira, Inc. (D. Del. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2021-11-15 | 1 | Complaint | ’399 patent”); 9,000,021 (“the ’021 patent”); and 9,579,384 (“the ’384 patent”) (“the Notice Letter Patents…the expiration of U.S. Patent No. 11,103,483 (“the ’483 patent” or “the Patent-in-Suit”). Case 1:21-…inter alia, U.S. Patent Nos. 9,034,908 (“the ’908 patent”); 9,144,568 (“the ’568 patent”); 9,572,887 (“…(“the ’887 patent”); 9,597,397 (“the ’397 patent”); 9,597,398 (“the ’398 patent”); 9,597,399 (“the ’399… 1. This is an action for patent infringement under the patent laws of the United States, Title | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |